Quick Comparison
| Huperzine A | Magnesium L-Threonate | |
|---|---|---|
| Half-Life | 10-14 hours | 2-3 hours (threonate carrier), but brain magnesium levels increase cumulatively |
| Typical Dosage | Standard: 50-200 mcg once or twice daily. Due to the long half-life, cycling is recommended (2 weeks on, 1 week off). Do not combine with prescription acetylcholinesterase inhibitors (donepezil, rivastigmine). | Standard: 1500-2000 mg Magnesium L-Threonate daily (providing 144 mg elemental magnesium). Often split into a daytime dose and a pre-bed dose. The Magtein brand uses 2000 mg daily (667 mg three times). |
| Administration | Oral (capsules, tablets). Well-absorbed orally. | Oral (capsules, powder). The L-threonate form is specifically chosen for brain penetration. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Huperzine A
Huperzine A is a potent, selective, and reversible inhibitor of acetylcholinesterase (AChE), binding to the enzyme's active site and preventing hydrolysis of acetylcholine to choline and acetate. By blocking AChE, it increases acetylcholine concentration in the synaptic cleft, prolonging activation of muscarinic (M1-M5) and nicotinic receptors. Huperzine A also blocks NMDA glutamate receptors in a non-competitive, use-dependent manner (similar to memantine), binding to the phencyclidine site within the ion channel and protecting neurons from excitotoxic calcium influx. It shows selectivity for the NR2A and NR2B subunits. Additionally, huperzine A has antioxidant properties, scavenging reactive oxygen species and reducing lipid peroxidation. It may enhance NGF signaling.
Magnesium L-Threonate
The L-threonate carrier forms stable complexes with magnesium and transports it across the blood-brain barrier via specific transporters more effectively than inorganic magnesium salts or other chelated forms. Once in the brain, magnesium acts as a voltage-dependent blocker of the NMDA receptor channel at the physiological magnesium binding site within the ion pore, preventing excessive calcium influx and glutamate-mediated excitotoxicity. Magnesium also serves as a cofactor for over 300 enzymes including those involved in neurotransmitter synthesis (tyrosine hydroxylase, glutamic acid decarboxylase), ATP production (creatine kinase, pyruvate kinase), and DNA/RNA polymerase. Elevated brain magnesium enhances synaptic density and plasticity in the hippocampus and prefrontal cortex, likely through CREB-mediated gene expression and increased density of postsynaptic AMPA receptors.
Risks & Safety
Huperzine A
Common
Nausea, diarrhea, sweating, muscle twitching.
Serious
Cholinergic crisis at high doses (excessive acetylcholine causing muscle weakness, breathing difficulty).
Rare
Blurred vision, slowed heart rate, seizures.
Magnesium L-Threonate
Common
Drowsiness (often desired for sleep), mild headache initially, gastrointestinal discomfort.
Serious
None documented at standard doses. Magnesium toxicity is not a concern with oral supplementation in people with normal kidney function.
Rare
Diarrhea (less common than with other magnesium forms).
Full Profiles
Huperzine A →
A naturally occurring alkaloid extracted from Chinese club moss (Huperzia serrata). It powerfully inhibits acetylcholinesterase — the enzyme that breaks down acetylcholine — resulting in significantly elevated acetylcholine levels in the brain. Used in Chinese medicine for centuries and now studied worldwide for Alzheimer's disease.
Magnesium L-Threonate →
A form of magnesium specifically designed to cross the blood-brain barrier and increase brain magnesium levels. Developed at MIT, it is the only magnesium form clinically shown to raise CSF magnesium concentrations. Brain magnesium is critical for synaptic plasticity, and deficiency (common in modern diets) impairs learning, memory, and sleep quality. Sold under the brand name Magtein.